Factors that Impact the Pharmacokinetic and Pharmacodynamic Effects of Cannabis: a Review of Human Laboratory Studies

被引:0
作者
C. Austin Zamarripa
Ryan Vandrey
Tory R. Spindle
机构
[1] Johns Hopkins University School of Medicine,Behavioral Pharmacology Research Unit, Department of Psychiatry & Behavioral Sciences
来源
Current Addiction Reports | 2022年 / 9卷
关键词
Cannabis; Pharmacokinetics; Pharmacodynamics; Route of administration; Cannabinoids;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:608 / 621
页数:13
相关论文
共 640 条
[1]  
Berg CJ(2015)Perceived harm, addictiveness, and social acceptability of tobacco products and marijuana among young adults: marijuana, hookah, and electronic cigarettes win Subst Use Misuse 50 79-89
[2]  
Stratton E(1973)Letter: cannabinoid phenotypes in Cannabis sativa Nature 245 147-148
[3]  
Schauer GL(2018)Pharmacological foundations of Cannabis chemovars Planta Med 84 225-233
[4]  
Lewis M(2010)Potency trends of D9-THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008 J Forensic Sci 55 1209-1217
[5]  
Wang Y(2018)Cannabis and cannabinoid drug development: evaluating botanical versus single molecule approaches Int Rev Psychiatry 30 277-284
[6]  
Small E(2008)The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin Br J Pharmacol 153 199-215
[7]  
Beckstead HD(2014)Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders Epilepsia 55 791-802
[8]  
Lewis MA(2016)Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: a review JAMA Psychiat 73 292-297
[9]  
Russo EB(2015)Cannabidiol as a potential treatment for anxiety disorders Neurotherapeutics 12 825-36
[10]  
Smith KM(2018)Review of the neurological benefits of phytocannabinoids Surg Neurol Int 9 91-4805